eClinical Technology and Industy News

AXIM® Biotechnologies Releases Preprint Manuscript Describing the Development of Company’s Rapid Point-of-Care Test That Measures COVID-19 Neutralizing Antibodies

Excerpt from the Press Release:

SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has released a preprint of its manuscript describing the development of ImmunoPass, the Company’s rapid point-of-care test that semi-quantitatively measures levels of neutralizing antibodies to COVID-19.

The manuscript is co-authored by several executives of AXIM’s subsidiary Sapphire Biotech, Inc., including Chief Clinical Officer Douglas F. Lake, Chief Scientific Officer Sergei Svarovsky and Chief Technology Officer Alim Seit-Nebi.

“This pandemic has caused massive economic and social unrest, not to mention the terrible loss of life and loved ones for millions of Americans. As COVID-19 vaccines roll out, recipients need to consistently monitor their levels of protective neutralizing antibodies. If vaccine-induced neutralizing antibodies decrease when compared to baseline, a vaccine booster may be necessary to keep everyone protected and prevent the spread of the virus. You can perform our test to indicate your level of protection while you drink your morning coffee. It’s fast, accurate, portable, and affordable when compared to similar tests,” said John W. Huemoeller II, Chief Executive Officer of AXIM® Biotech.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary Data Management

Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives